These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37546414)

  • 21. Increased expression of miR-330-3p: a novel independent indicator of poor prognosis in human breast cancer.
    Wang H; Chen SH; Kong P; Zhang LY; Zhang LL; Zhang NQ; Gu H
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1726-1730. PubMed ID: 29630118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer.
    Yan LX; Liu YH; Xiang JW; Wu QN; Xu LB; Luo XL; Zhu XL; Liu C; Xu FP; Luo DL; Mei P; Xu J; Zhang KP; Chen J
    Int J Oncol; 2016 Feb; 48(2):471-84. PubMed ID: 26676464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-338-3p inhibits the progression of bladder cancer through regulating ETS1 expression.
    Zhang L; Yan R; Zhang SN; Zhang HZ; Ruan XJ; Cao Z; Gu XZ
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1986-1995. PubMed ID: 30915741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiR-185-3p regulates epithelial mesenchymal transition via PI3K/Akt signaling pathway by targeting cathepsin D in gastric cancer cells.
    Huang C; Wu YJ; He WF; Zhao SL; Ouyang YY; Ai XH; Liu ZQ; Tang SY
    Transl Cancer Res; 2020 Nov; 9(11):6988-7000. PubMed ID: 35117305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of potential microRNA diagnostic panels and uncovering regulatory mechanisms in breast cancer pathogenesis.
    Sharifi Z; Talkhabi M; Taleahmad S
    Sci Rep; 2022 Nov; 12(1):20135. PubMed ID: 36418345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miRNA-506-3p Directly Regulates rs10754339 (A/G) in the Immune Checkpoint Protein B7-H4 in Breast Cancer.
    El Din GS; Youness RA; Assal RA; Gad MZ
    Microrna; 2020; 9(5):346-353. PubMed ID: 33297930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of low molecular weight-polycyclic aromatic hydrocarbons responsive hsa_circ_0039929/hsa-miR-15b-3p_R-1/FGF2 circuit on inflammatory response of A549 cells via the PI3K/AKT pathway and epithelial-mesenchymal transition process.
    Huang Y; Huang Y; Wang H; Zhang H; Shi L; Li C; Li X; Zeng Y; Liu Y; Wu M; Wang J; Wang J
    Environ Toxicol; 2022 Aug; 37(8):2005-2018. PubMed ID: 35475590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. circRNA RPPH1 Facilitates the Aggravation of Breast Cancer Development by Regulating miR-542-3p/ARHGAP1 Pathway.
    Qi L; Sun B; Yang B; Lu S
    Cancer Biother Radiopharm; 2022 Oct; 37(8):708-719. PubMed ID: 34402683
    [No Abstract]   [Full Text] [Related]  

  • 29. Regulation of cancerous progression and epithelial-mesenchymal transition by miR-34c-3p via modulation of MAP3K2 signaling in triple-negative breast cancer cells.
    Wu J; Li WZ; Huang ML; Wei HL; Wang T; Fan J; Li NL; Ling R
    Biochem Biophys Res Commun; 2017 Jan; 483(1):10-16. PubMed ID: 28069384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpressed VDAC1 in breast cancer as a novel prognostic biomarker and correlates with immune infiltrates.
    Fang Y; Liu J; Zhang Q; She C; Zheng R; Zhang R; Chen Z; Chen C; Wu J
    World J Surg Oncol; 2022 Jun; 20(1):211. PubMed ID: 35729567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upregulation of microRNA-140-3p inhibits epithelial-mesenchymal transition, invasion, and metastasis of hepatocellular carcinoma through inactivation of the MAPK signaling pathway by targeting GRN.
    Zhang QY; Men CJ; Ding XW
    J Cell Biochem; 2019 Sep; 120(9):14885-14898. PubMed ID: 31044454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of lncRNA TRPM2-AS/miR-140-3p/PYCR1 axis's proliferates and anti-apoptotic effect on breast cancer using co-expression network analysis.
    Sun T; Song Y; Yu H; Luo X
    Cancer Biol Ther; 2019; 20(6):760-773. PubMed ID: 30810442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-325-3p Promotes the Proliferation, Invasion, and EMT of Breast Cancer Cells by Directly Targeting S100A2.
    Wang H; Hu X; Yang F; Xiao H
    Oncol Res; 2021 Sep; 28(7):731-744. PubMed ID: 33419488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.
    Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM
    Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA MALAT1 promotes breast cancer progression and doxorubicin resistance via regulating miR-570-3p.
    Yue X; Wu WY; Dong M; Guo M
    Biomed J; 2021 Dec; 44(6 Suppl 2):S296-S304. PubMed ID: 35410813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anhydroicaritin Inhibits EMT in Breast Cancer by Enhancing GPX1 Expression: A Research Based on Sequencing Technologies and Bioinformatics Analysis.
    Li F; Shi Y; Yang X; Luo Z; Zhang G; Yu K; Li F; Chen L; Zhao Y; Xie Y; Wu Y; Yang J; Zhou X; Liu S
    Front Cell Dev Biol; 2021; 9():764481. PubMed ID: 35178395
    [No Abstract]   [Full Text] [Related]  

  • 37. Circular RNA_0000326 promotes bladder cancer progression via microRNA-338-3p/ETS Proto-Oncogene 1/phosphoinositide-3 kinase/Akt pathway.
    Chen Y; Wang D; Shu T; Sun K; Zhao J; Wang M; Huang Y; Wang P; Zheng H; Cai Z; Yang Z
    Bioengineered; 2021 Dec; 12(2):11410-11422. PubMed ID: 34889689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NONHSAT021545/miR-330-3p/EREG: A Cooperative Axis in Breast Cancer Prognosis and Treatment.
    Zhang Y; Guo C; Yang S; Elkharti M; Liu R; Sun MZ; Liu S
    J Clin Med; 2023 Mar; 12(7):. PubMed ID: 37048561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of downregulated miR-133a-3p expression in bladder cancer: a bioinformatics study.
    Gao L; Li SH; Tian YX; Zhu QQ; Chen G; Pang YY; Hu XH
    Onco Targets Ther; 2017; 10():3667-3683. PubMed ID: 28790856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN.
    Cai LM; Lyu XM; Luo WR; Cui XF; Ye YF; Yuan CC; Peng QX; Wu DH; Liu TF; Wang E; Marincola FM; Yao KT; Fang WY; Cai HB; Li X
    Oncogene; 2015 Apr; 34(17):2156-66. PubMed ID: 25347742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.